Effect of Probiotic Inersan and Doxycycline in Chronic Periodontitis
Launched by CD PHARMA INDIA PVT. LTD. · Jun 24, 2014
Trial Information
Current as of May 06, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Subjects in both sexes
- • 2. Age 25 - 60 yrs
- • 3. Subjects with mild to moderate chronic periodontitis, as defined by probing pocket depths ≥ 5mm in \> 30 % of the probing sites
- • 4. Subjects in good general health
- Exclusion Criteria:
- • 1. Antibiotic therapy in the past 2 months
- • 2. Allergic to doxycycline or probiotics
- • 3. Subjects with diabetic mellitus, hypertension and psychiatric disorders
- • 4. Subjects who are pregnant/ lactating
- • 5. Smokers and/or alcoholics
- • 6. Subjects who have undergone any periodontal therapy within last 6 months.
About Cd Pharma India Pvt. Ltd.
CD Pharma India Pvt. Ltd. is a leading pharmaceutical company dedicated to advancing healthcare through innovative research and development. With a strong commitment to quality and compliance, the company specializes in the formulation and manufacturing of a wide range of pharmaceutical products, including generic medications and specialty therapeutics. CD Pharma's clinical trials aim to enhance treatment options and improve patient outcomes, leveraging state-of-the-art technology and a team of experienced professionals. The organization is focused on ensuring safety, efficacy, and regulatory adherence in all its clinical research endeavors, positioning itself as a trusted partner in the global pharmaceutical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kulasekharam, Tamil Naidu, India
Patients applied
Trial Officials
Arya K.S., BDS
Principal Investigator
Sree Mookambika Institute of Dental Sciences
Elizabeth Koshi, MDS
Study Director
Sree Mookambika Institute of Dental Sciences
Arun Sadasivan, MDS
Principal Investigator
Sree Mookambika Institute of Dental Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials